Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07110688 · ClinicalTrials.gov registry record · NA
Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States
A NA study of No Condition and Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 2
- Study locations
NCT07110688: Recruiting NA study of No Condition and Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG, sponsored by University of Southern California.
NCT07110688 is a NA study of No Condition and Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07110688, a NA study of No Condition and Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
In this program, the investigators will develop novel multimodal neural-behavioral-physiological monitoring tools (software and hardware), and machine learning models for mental states within social processes and beyond. The tools consist of a multimodal skin-like wearable sensor for physiological and biochemical sensing; a conversational virtual human platform to evoke naturalistic social processes; audiovisual affect recognition software; synchronization tools; and machine learning methods to model the multimodal data. The investigators will demonstrate the tools in healthy subjects without neural recordings and in patients with drug-resistant epilepsy who already have intracranial EEG (iEEG) electrodes implanted based on clinical criteria for standard monitoring to localize seizures, which is unrelated to our study.
Primary Outcome
Momentary self-reports of the Positive and Negative Affect Schedule (PANAS) will be administered in a tablet-based application, which measures momentary positive and negative affect. These self-reports return scores indicative of momentary mental state. Self-reports are obtained intermittently from the participants.
Conditions Studied
Interventions
- BEHAVIORAL Virtual human social interaction
- BEHAVIORAL Cold pressor test
Study Locations (2)
California
- Rancho Los Amigos National Rehabilitation Center - Downey
- University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2028-11-30 |
| Phase | NA |
What NCT07110688 shows while recruiting
NCT07110688 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with No Condition appearing as the primary indexed condition, and to 2 interventions - of which Virtual human social interaction is the first listed.
NCT07110688 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07110688 about?
NCT07110688 is a clinical study titled "Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States". In this program, the investigators will develop novel multimodal neural-behavioral-physiological monitoring tools (software and hardware), and machine learning models for mental states within social processes and beyond. The tools consist of a multimodal skin-like wearable sensor for physiological a...
What is the current status of trial NCT07110688?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-08-01. Estimated completion is 2028-11-30.
What conditions does trial NCT07110688 study?
This clinical trial studies the following conditions: No Condition, Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG.
What interventions are being tested in trial NCT07110688?
The interventions under investigation include: Virtual human social interaction (BEHAVIORAL), Cold pressor test (BEHAVIORAL).
Who is sponsoring clinical trial NCT07110688?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07110688 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for No Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07110688's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI